Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis

Neuroepidemiology. Mar-Apr 2003;22(2):106-17. doi: 10.1159/000068744.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use*
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Intracranial Arteriosclerosis / complications*
  • Intracranial Arteriosclerosis / drug therapy*
  • Intracranial Arteriosclerosis / mortality
  • Ischemic Attack, Transient / etiology*
  • Ischemic Attack, Transient / mortality
  • Ischemic Attack, Transient / prevention & control*
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Program Development*
  • Prospective Studies
  • Research Design*
  • Stroke / etiology*
  • Stroke / mortality
  • Stroke / prevention & control*
  • Survival Rate
  • Time Factors
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Aspirin